TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 105 filers reported holding TG THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,255,588 | -65.4% | 150,190 | +2.9% | 0.00% | -66.7% |
Q2 2023 | $3,626,988 | +42.8% | 146,014 | -13.5% | 0.00% | +50.0% |
Q1 2023 | $2,539,399 | +17.8% | 168,843 | -7.3% | 0.00% | 0.0% |
Q4 2022 | $2,155,580 | +87.6% | 182,213 | -6.1% | 0.00% | +100.0% |
Q3 2022 | $1,149,000 | +53.0% | 194,138 | +9.9% | 0.00% | 0.0% |
Q2 2022 | $751,000 | -52.4% | 176,644 | +6.4% | 0.00% | 0.0% |
Q1 2022 | $1,579,000 | -47.8% | 165,994 | +4.3% | 0.00% | -50.0% |
Q4 2021 | $3,024,000 | -49.4% | 159,134 | -11.4% | 0.00% | -60.0% |
Q3 2021 | $5,981,000 | -21.0% | 179,705 | -8.0% | 0.01% | -28.6% |
Q2 2021 | $7,574,000 | -23.3% | 195,267 | -4.7% | 0.01% | -30.0% |
Q1 2021 | $9,881,000 | -10.4% | 204,992 | -10.3% | 0.01% | -16.7% |
Q4 2020 | $11,032,000 | +90.8% | 228,521 | +5.8% | 0.01% | +71.4% |
Q3 2020 | $5,783,000 | +24.0% | 216,095 | -9.8% | 0.01% | +16.7% |
Q2 2020 | $4,665,000 | +73.3% | 239,482 | -12.5% | 0.01% | +50.0% |
Q1 2020 | $2,692,000 | -24.6% | 273,567 | -14.9% | 0.00% | -20.0% |
Q4 2019 | $3,570,000 | +91.1% | 321,632 | -3.3% | 0.01% | +66.7% |
Q3 2019 | $1,868,000 | -31.0% | 332,649 | +6.3% | 0.00% | -25.0% |
Q2 2019 | $2,708,000 | -11.7% | 313,020 | -17.9% | 0.00% | -20.0% |
Q1 2019 | $3,067,000 | +126.7% | 381,437 | +15.6% | 0.01% | +150.0% |
Q4 2018 | $1,353,000 | +3.4% | 330,019 | +41.3% | 0.00% | 0.0% |
Q3 2018 | $1,308,000 | -8.1% | 233,634 | +115.8% | 0.00% | 0.0% |
Q2 2018 | $1,424,000 | -55.6% | 108,282 | -52.1% | 0.00% | -66.7% |
Q1 2018 | $3,209,000 | +85.0% | 226,017 | +6.8% | 0.01% | +100.0% |
Q4 2017 | $1,735,000 | +64.1% | 211,595 | +137.2% | 0.00% | +50.0% |
Q3 2017 | $1,057,000 | +26.0% | 89,195 | +6.8% | 0.00% | 0.0% |
Q2 2017 | $839,000 | -31.9% | 83,508 | -21.0% | 0.00% | -33.3% |
Q1 2017 | $1,232,000 | +407.0% | 105,762 | +102.1% | 0.00% | +200.0% |
Q4 2016 | $243,000 | +32.8% | 52,320 | +121.6% | 0.00% | – |
Q3 2016 | $183,000 | +96.8% | 23,612 | +53.3% | 0.00% | – |
Q2 2016 | $93,000 | -20.5% | 15,400 | +12.3% | 0.00% | – |
Q1 2016 | $117,000 | -59.5% | 13,719 | -21.2% | 0.00% | -100.0% |
Q2 2015 | $289,000 | -2.0% | 17,413 | -8.7% | 0.00% | 0.0% |
Q1 2015 | $295,000 | – | 19,075 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |